4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide

C134H145ClF3N41O18S — CID 159533841

IUPAC4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
SMILESCOc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ccc(C(F)(F)F)cn4)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ncccn4)CC3)[nH]c2cc1OC.COc1ccc(OC)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c1.CS(=O)(=O)N1CCC(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.N#CC1(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(Cl)cc1
InChIInChI=1S/C24H24F3N7O3.C24H26N6O4.C22H21ClN6O2.C22H24N8O3.C22H29N7O4S.C20H21N7O2/c1-36-18-9-15-16(10-19(18)37-2)31-22(30-15)21-17(12-29-33-21)32-23(35)13-5-7-34(8-6-13)20-4-3-14(11-28-20)24(25,26)27;1-32-16-4-6-21(33-2)17(12-16)24(31)28-20-13-25-29-22(20)23-26-18-5-3-15(11-19(18)27-23)14-30-7-9-34-10-8-30;23-16-4-2-15(3-5-16)22(30)27-19-12-24-28-20(19)21-25-17-6-1-14(11-18(17)26-21)13-29-7-9-31-10-8-29;1-32-17-10-14-15(11-18(17)33-2)27-20(26-14)19-16(12-25-29-19)28-21(31)13-4-8-30(9-5-13)22-23-6-3-7-24-22;1-34(31,32)29-6-4-16(5-7-29)22(30)26-19-13-23-27-20(19)21-24-17-3-2-15(12-18(17)25-21)14-28-8-10-33-11-9-28;21-12-20(3-4-20)19(28)25-16-10-22-26-17(16)18-23-14-2-1-13(9-15(14)24-18)11-27-5-7-29-8-6-27/h3-4,9-13H,5-8H2,1-2H3,(H,29,33)(H,30,31)(H,32,35);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);1-6,11-12H,7-10,13H2,(H,24,28)(H,25,26)(H,27,30);3,6-7,10-13H,4-5,8-9H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);2-3,12-13,16H,4-11,14H2,1H3,(H,23,27)(H,24,25)(H,26,30);1-2,9-10H,3-8,11H2,(H,22,26)(H,23,24)(H,25,28)
InChIKeyMDIMEPKXAOWISJ-UHFFFAOYSA-N
MW2742.42 g/mol
LogP17.02
Rot. Bonds35

About 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide

4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide (PubChem CID 159533841) has the molecular formula C134H145ClF3N41O18S and a molecular weight of 2742.42 g/mol. Its IUPAC name is 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide.

Molecular Properties

Compound Name4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
PubChem CID159533841
Molecular FormulaC134H145ClF3N41O18S
Molecular Weight2742.42 g/mol
Exact Mass2740.11
IUPAC Name4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
SMILESCOc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ccc(C(F)(F)F)cn4)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ncccn4)CC3)[nH]c2cc1OC.COc1ccc(OC)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c1.CS(=O)(=O)N1CCC(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.N#CC1(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(Cl)cc1
InChIInChI=1S/C24H24F3N7O3.C24H26N6O4.C22H21ClN6O2.C22H24N8O3.C22H29N7O4S.C20H21N7O2/c1-36-18-9-15-16(10-19(18)37-2)31-22(30-15)21-17(12-29-33-21)32-23(35)13-5-7-34(8-6-13)20-4-3-14(11-28-20)24(25,26)27;1-32-16-4-6-21(33-2)17(12-16)24(31)28-20-13-25-29-22(20)23-26-18-5-3-15(11-19(18)27-23)14-30-7-9-34-10-8-30;23-16-4-2-15(3-5-16)22(30)27-19-12-24-28-20(19)21-25-17-6-1-14(11-18(17)26-21)13-29-7-9-31-10-8-29;1-32-17-10-14-15(11-18(17)33-2)27-20(26-14)19-16(12-25-29-19)28-21(31)13-4-8-30(9-5-13)22-23-6-3-7-24-22;1-34(31,32)29-6-4-16(5-7-29)22(30)26-19-13-23-27-20(19)21-24-17-3-2-15(12-18(17)25-21)14-28-8-10-33-11-9-28;21-12-20(3-4-20)19(28)25-16-10-22-26-17(16)18-23-14-2-1-13(9-15(14)24-18)11-27-5-7-29-8-6-27/h3-4,9-13H,5-8H2,1-2H3,(H,29,33)(H,30,31)(H,32,35);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);1-6,11-12H,7-10,13H2,(H,24,28)(H,25,26)(H,27,30);3,6-7,10-13H,4-5,8-9H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);2-3,12-13,16H,4-11,14H2,1H3,(H,23,27)(H,24,25)(H,26,30);1-2,9-10H,3-8,11H2,(H,22,26)(H,23,24)(H,25,28)
InChIKeyMDIMEPKXAOWISJ-UHFFFAOYSA-N
XLogP17.02
TPSA730.34 Ų
H-Bond Donors18
H-Bond Acceptors40
Rotatable Bonds35
Heavy Atoms198
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002742.42
LogP ≤ 517.02
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1040

Analyze 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The IUPAC name of 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide (CID 159533841) is 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide.
What is the SMILES notation for 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The canonical SMILES for 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide is COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ccc(C(F)(F)F)cn4)CC3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ncccn4)CC3)[nH]c2cc1OC.COc1ccc(OC)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c1.CS(=O)(=O)N1CCC(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.N#CC1(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)CC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(Cl)cc1.
What is the InChIKey of 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The InChIKey is MDIMEPKXAOWISJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H24F3N7O3.C24H26N6O4.C22H21ClN6O2.C22H24N8O3.C22H29N7O4S.C20H21N7O2/c1-36-18-9-15-16(10-19(18)37-2)31-22(30-15)21-17(12-29-33-21)32-23(35)13-5-7-34(8-6-13)20-4-3-14(11-28-20)24(25,26)27;1-32-16-4-6-21(33-2)17(12-16)24(31)28-20-13-25-29-22(20)23-26-18-5-3-15(11-19(18)27-23)14-30-7-9-34-10-8-30;23-16-4-2-15(3-5-16)22(30)27-19-12-24-28-20(19)21-25-17-6-1-14(11-18(17)26-21)13-29-7-9-31-10-8-29;1-32-17-10-14-15(11-18(17)33-2)27-20(26-14)19-16(12-25-29-19)28-21(31)13-4-8-30(9-5-13)22-23-6-3-7-24-22;1-34(31,32)29-6-4-16(5-7-29)22(30)26-19-13-23-27-20(19)21-24-17-3-2-15(12-18(17)25-21)14-28-8-10-33-11-9-28;21-12-20(3-4-20)19(28)25-16-10-22-26-17(16)18-23-14-2-1-13(9-15(14)24-18)11-27-5-7-29-8-6-27/h3-4,9-13H,5-8H2,1-2H3,(H,29,33)(H,30,31)(H,32,35);3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);1-6,11-12H,7-10,13H2,(H,24,28)(H,25,26)(H,27,30);3,6-7,10-13H,4-5,8-9H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);2-3,12-13,16H,4-11,14H2,1H3,(H,23,27)(H,24,25)(H,26,30);1-2,9-10H,3-8,11H2,(H,22,26)(H,23,24)(H,25,28).
What are the key properties of 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide has a molecular weight of 2742.42 g/mol, XLogP of 17.02, 35 rotatable bonds, 18 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 4-chloro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-cyano-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]cyclopropane-1-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-[5-(trifluoromethyl)-2-pyridinyl]piperidine-4-carboxamide;2,5-dimethoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;1-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide is sourced from PubChem (CID 159533841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).